Nobuko Serizawa

646 total citations
18 papers, 535 citations indexed

About

Nobuko Serizawa is a scholar working on Oncology, Immunology and Hepatology. According to data from OpenAlex, Nobuko Serizawa has authored 18 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 5 papers in Hepatology. Recurrent topics in Nobuko Serizawa's work include Liver physiology and pathology (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Nobuko Serizawa is often cited by papers focused on Liver physiology and pathology (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Nobuko Serizawa collaborates with scholars based in Japan, United States and Russia. Nobuko Serizawa's co-authors include Xiangling Chen, Joy X. Jiang, Natalie J. Török, Sridevi Devaraj, Patrick Page, Cédric Szyndralewiez, Katrin Schröder, Ralf P. Brandes, Fiona L. Scott and R. H. Adamson and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Nobuko Serizawa

17 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuko Serizawa Japan 7 205 182 173 145 73 18 535
Carlos Sanz‐García Spain 10 297 1.4× 89 0.5× 132 0.8× 218 1.5× 55 0.8× 20 542
Lukas Geisler Germany 9 249 1.2× 144 0.8× 87 0.5× 216 1.5× 97 1.3× 17 535
Yukio Kume Japan 12 196 1.0× 203 1.1× 71 0.4× 447 3.1× 70 1.0× 18 737
Michael K. Connolly United States 7 192 0.9× 197 1.1× 229 1.3× 107 0.7× 78 1.1× 8 554
Ning‐Ping Zhang China 13 495 2.4× 337 1.9× 104 0.6× 215 1.5× 59 0.8× 28 768
Juanjuan Shi China 16 216 1.1× 148 0.8× 171 1.0× 241 1.7× 183 2.5× 32 725
Tixiao Wang China 12 123 0.6× 69 0.4× 257 1.5× 290 2.0× 73 1.0× 18 654
Tamara Severi Belgium 9 238 1.2× 287 1.6× 34 0.2× 198 1.4× 96 1.3× 10 604
Masao Omata Japan 10 234 1.1× 297 1.6× 97 0.6× 199 1.4× 230 3.2× 19 753
Pei Kee Goh Australia 6 195 1.0× 84 0.5× 182 1.1× 285 2.0× 23 0.3× 8 564

Countries citing papers authored by Nobuko Serizawa

Since Specialization
Citations

This map shows the geographic impact of Nobuko Serizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuko Serizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuko Serizawa more than expected).

Fields of papers citing papers by Nobuko Serizawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuko Serizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuko Serizawa. The network helps show where Nobuko Serizawa may publish in the future.

Co-authorship network of co-authors of Nobuko Serizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuko Serizawa. A scholar is included among the top collaborators of Nobuko Serizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuko Serizawa. Nobuko Serizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sugimoto, Kiichi, Shingo Kawano, Shinya Munakata, et al.. (2022). CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer. Anticancer Research. 42(2). 697–707. 5 indexed citations
2.
Fukushima, Hirofumi, Tomoyoshi Shibuya, Keiichi Haga, et al.. (2021). CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor. Internal Medicine. 61(10). 1497–1501. 2 indexed citations
3.
Serizawa, Nobuko, Jijing Tian, Kornélia Baghy, et al.. (2015). Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation. Laboratory Investigation. 95(10). 1145–1156. 37 indexed citations
4.
Serizawa, Nobuko, Junko Kato, Tomohiro Kodani, et al.. (2015). Management tips for the low incidence, of adverse events and well efficacy of regorafenib for metastatic colorectal cancer in Juntendo University Medical Hospital.. Journal of Clinical Oncology. 33(3_suppl). 778–778. 1 indexed citations
5.
Kato, Junko, Akihito Nagahara, Kentaro Izumi, et al.. (2013). Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. International Journal of Oncology. 44(3). 662–668. 32 indexed citations
6.
7.
Jiang, Joy X., Xiangling Chen, Nobuko Serizawa, et al.. (2012). Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radical Biology and Medicine. 53(2). 289–296. 210 indexed citations
8.
Jiang, Joy X., Xiangling Chen, Daniel K. Hsu, et al.. (2011). Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. American Journal of Physiology-Gastrointestinal and Liver Physiology. 302(4). G439–G446. 72 indexed citations
9.
Jiang, Joy X., Senthil Kumar Venugopal, Nobuko Serizawa, et al.. (2010). Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo. Gastroenterology. 139(4). 1375–1384.e4. 99 indexed citations
10.
Mori, Hiroki, Tomoyoshi Shibuya, Taro Osada, et al.. (2010). Response to chemotherapy in a case of gastric adenocarcinoma producing granulocyte colony-stimulating factor.. PubMed. 16(10). CS119–23. 6 indexed citations
11.
Kato, Jun, Akihito Nagahara, Tomohiro Kodani, et al.. (2010). Phase I study of Paclitaxel, Cisplatin and 5-fluorouracil combination chemotherapy for unresectable / recurrent gastric cancer. Advances in Medical Sciences. 55(2). 137–142. 6 indexed citations
12.
Okubo, Hironao, Yoshiyuki Takei, Nobuko Serizawa, et al.. (2006). Orthotopic hepatocellular carcinoma model with a controlled and reproducible tumorigenicity. Journal of Gastroenterology and Hepatology. 22(3). 423–428. 5 indexed citations
13.
14.
Ohta, Kazuki, Akihito Nagahara, Junko Kato, et al.. (2006). Metallic stents provide better QOL than plastic stents in patients with stricture of unresectable advanced esophageal cancer.. Juntendō Igaku. 52(4). 560–565.
15.
Nagahara, Akihito, Nobuko Serizawa, Junko Kato, et al.. (2006). A case of juvenile-onset familial multiple gastric carcinoma. Progress of Digestive Endoscopy. 68(2). 110–111. 1 indexed citations
16.
Onuma, Tomio, et al.. (2003). A case suspected of diabetes mellitus characterized by rapid onset and absence of diabetes-related antibodies. Juntendō Igaku. 48(4). 516–519. 2 indexed citations
17.
Serizawa, Nobuko, et al.. (1992). A histological study of changes in the lingual papillae of streptozotocin-induced diabetic rats.. PubMed. 33(1). 13–24. 10 indexed citations
18.
Serizawa, Nobuko. (1988). [An electron microscopic study on the capillaries of buccal mucosa and retina in streptozotocin-induced diabetic rats].. PubMed. 88(1). 85–109. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Sanz‐García Breakdown of academic impact, for papers by Lukas Geisler Breakdown of academic impact, for papers by Yukio Kume Breakdown of academic impact, for papers by Michael K. Connolly Breakdown of academic impact, for papers by Ning‐Ping Zhang Breakdown of academic impact, for papers by Juanjuan Shi Breakdown of academic impact, for papers by Tixiao Wang Breakdown of academic impact, for papers by Tamara Severi Breakdown of academic impact, for papers by Masao Omata Breakdown of academic impact, for papers by Pei Kee Goh
Rankless by CCL
2026